Status:
COMPLETED
Bupropion for Smoking Cessation in Pregnancy
Lead Sponsor:
Watching Over Mothers & Babies Foundation
Collaborating Sponsors:
University of Arizona
Conditions:
Smoking Cessation
Pregnancy
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether bupropion SR increases cessation and/or smoking reduction among pregnant smokers.
Detailed Description
Primary Objective: To evaluate the efficacy of a pharmacologic agent (bupropion SR) to achieve higher rates of smoking cessation and greater reduction in smoking during pregnancy Secondary Objective...
Eligibility Criteria
Inclusion
- Smoked at least one puff in the past 7 days
- Confirmed viable gestation
Exclusion
- All patients found to have a non-viable fetus or major congenital anomaly
- History of seizure disorder
- Family history of seizure disorder
- History of severe head trauma
- History of anorexia nervosa or bulimia
- Current use of nicotine-replacement therapy
- Unstable medical or psychiatric condition
- Current use of an monoamine oxidase inhibitor or bupropion hydrochloride products
Key Trial Info
Start Date :
October 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2004
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT01875172
Start Date
October 1 2001
End Date
January 1 2004
Last Update
June 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Watching over Mothers and Babies Foundation
Tucson, Arizona, United States, 85712